Investors & Media Value through vision

ProQR scientist in the lab

Located in Leiden, Netherlands and Cambridge, Mass., ProQR Therapeutics (Nasdaq:PRQR) is a clinical-stage biotechnology company developing RNA therapies for the treatment of severe genetic rare diseases with a focus on inherited blindness.

Corporate presentation

View the latest ProQR corporate presentation

Internal link Download presentation
ProQR Corporate Presentation

Events

A list of past and future conferences and events

Where to meet us

events icon

Financial information

Latest SEC filings, annual reports and AGM documents

View details

Financial information icon

Presentations and publications

The latest scientific publications for our development programs

View scientific publications

presentations and publications icon

Corporate governance

Documents related to corporate governance

Go to documents

corporate governance icon

Analysts

A list of the analysts that cover ProQR

See the list

analysts icon

ProQR Share Performance

View $PRQR share performance

Press Releases

Internal link More press releases
Female scientist working in the lab